Diclofenac/menthol

Drug Profile

Diclofenac/menthol

Alternative Names: Diclofenac-menthol; Menthol/diclofenac; MFC 51123

Latest Information Update: 11 Apr 2017

Price : $50

At a glance

  • Originator GlaxoSmithKline
  • Class Cyclohexanols; Monoterpenes; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 11 Apr 2017 Discontinued - Phase-I for Pain (In volunteers) in USA (Topical), because not listed on GSK pipeline, April 2017
  • 11 Apr 2017 Discontinued - Phase-III for Pain in Germany (Topical), because not listed on GSK pipeline, April 2017
  • 01 Mar 2015 GlaxoSmithKline completes a phase III trial in Pain in Germany (NCT02100670)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top